authors
- Martin M.
- Candel M.T.
- Albanell J.
- Aranda E.
- Munarriz B.
- Campbell J.
- Díaz-Rubio E.
- Villar A.
- Sole-Calvo A.
- González R.
- Massuti B.
- Lizon J.
- Camps C.
- CARRATO MENA, ALFREDO
- Casado A.
FAC (fluorouracil, doxorubicin, cyclophosphamide) versus CMF (cyclophosphamide, methotrexate, fluorouracil) as adjuvant chemotherapy for operable breast cancer: A study by the GEICAM group.
Academic Article
2003
- Overview
- Additional Document Info
- Ver todos